GLP-1 medications, such as Ozempic, Wegovy, and Mounjaro, can treat diabetes and weight management.
With the surge in popularity of these drugs, many are left wondering what type of patient is the best candidate for these pricey drugs?
In the fourth part of Omada’s video blog series, Chief Medical Officer Carolyn Bradner Jasik, MD is covering her stance on what patients would benefit most by taking GLP-1s for weight management.
